Enterome Reports Positive Phase 2 EO2463 Results
Paris, France | July 21, 2026 Enterome SA announced positive interim Phase 1/2 clinical data from its ongoing SIDNEY...
follicular lymphoma
Advertisement
Montefiore Einstein Expands CGM Use to Improve Diabetes Care
BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...
AMO Pharma Aligns Global Trial Plan for AMO-02 in cDM1
LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...
AbbVie Wins EU Approval for TEPKINLY in Follicular Lymphoma
NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...
Genmab Wins EU Approval for TEPKINLY Plus R2
COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...
Advertisements
Genmab Reports Positive EPCORE FL-1 Data for Epcoritamab Combination
COPENHAGEN, Denmark, June 11, 2026 Genmab A/S announced new subgroup analysis results from the pivotal Phase 3 EPCORE FL-1...
PeproMene Bio CAR-T Therapy Shows Durable Lymphoma Responses
IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...
Enterome Wins FDA Orphan Tag for EO2463 in iNHL
Paris, France | May 28, 2026 Enterome announced that the U.S. FDA has granted Orphan Drug Designation (ODD) to...
AbbVie’s Epkinly Gets FDA Nod for Follicular Lymphoma Combo
NORTH CHICAGO, IL – November 18, 2025 — AbbVie announced that the U.S. Food and Drug Administration (FDA) has...
Boston Scientific to Acquire Nalu Medical for Pain Therapy Expansion
Marlborough, MA – October 17, 2025 – Boston Scientific Corporation announced that it has entered into a definitive agreement...
Advertisement
